ArticlePhotoacoustics2026
Frequency-domain photoacoustic microscopy with resonant transducer and interferometric modulation for high-reliability sO
Article in Photoacoustics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Frequency-domain photoacoustic microscopy (FD-PAM) could leverage a high-Q resonant ultrasound transducer to suppress out-of-band noise and lower the noise-equivalent pressure (NEP) for truly simultaneous multi-wavelength functional imaging. In practice, however, conventional continuous-wave direct modulation makes it difficult to stay within the narrow resonance, leading most implementations to rely on low-Q broadband detectors instead. To obtain accurate and stable hemoglobin oxygen saturation (sO₂) measurements, we implement an acousto-optic modulator (AOM)-based interferometric modulation scheme in FD-PAM, enabling the practical use of a high-Q resonant ultrasound transducer while preserving truly simultaneous dual-wavelength excitation. FD-PAM with interferometric modulation operates robustly within the narrow bandwidth of the high-Q transducer and supports clean spectral separation (SSIM = 0.97 between frequency-separated channels), as well as quantitative sO₂ estimation with < 2% within-group variation across oxygenated, mixed, and deoxygenated conditions. We anticipate that this approach will be useful for monitoring drug-induced changes in hemoglobin oxygen saturation and quantitatively evaluating therapeutic response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.